Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02991677

Exercise Effect on Chemotherapy-Induced Neuropathic Pain

Exercise Effect on Chemotherapy-Induced Neuropathic Pain, Peripheral Nerve Fibers

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Baltimore VA Medical Center · Federal
Sex
All
Age
21 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Chemotherapy-induced peripheral neuropathy (CIPN) continues to be a serious healthcare concern. It is painful, persistent, resistant to conventional pain therapies, and results in long-term suffering and decreased quality of life for many cancer survivors. The role of exercise to decrease CIPN-related neuropathic pain (CIPN-NP) will be investigated, with the goal of identifying the mechanisms associated with this therapeutic approach to manage CIPN-NP.

Conditions

Interventions

TypeNameDescription
BEHAVIORALaerobic exercise interventionExercise physiologist supervised walking or running on the treadmill 3 times weekly for 12 weeks.
OTHERcontrol groupweekly contact by study staff with survivorship information offered not related to neuropathy.
BEHAVIORALresistive trainingExercise physiologist supervised upper and lower extremity resistive training 3 times weekly for 12 weeks

Timeline

Start date
2018-03-01
Primary completion
2025-06-01
Completion
2025-12-01
First posted
2016-12-13
Last updated
2024-08-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02991677. Inclusion in this directory is not an endorsement.